tiprankstipranks
Autonomix Medical, Inc. (AMIX)
NASDAQ:AMIX
US Market
Holding AMIX?
Track your performance easily

Autonomix Medical, Inc. (AMIX) Stock Price & Analysis

80 Followers

AMIX Stock Chart & Stats


Financials

Annual

Ownership Overview

0.14%99.71%
Insiders
― Other Institutional Investors
99.71% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

AMIX FAQ

What was Autonomix Medical, Inc.’s price range in the past 12 months?
Autonomix Medical, Inc. lowest stock price was $5.85 and its highest was $152.00 in the past 12 months.
    What is Autonomix Medical, Inc.’s market cap?
    Currently, no data Available
    When is Autonomix Medical, Inc.’s upcoming earnings report date?
    Autonomix Medical, Inc.’s upcoming earnings report date is Nov 11, 2024 which is 12 days ago.
      How were Autonomix Medical, Inc.’s earnings last quarter?
      Currently, no data Available
      Is Autonomix Medical, Inc. overvalued?
      According to Wall Street analysts Autonomix Medical, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Autonomix Medical, Inc. pay dividends?
        Autonomix Medical, Inc. does not currently pay dividends.
        What is Autonomix Medical, Inc.’s EPS estimate?
        Autonomix Medical, Inc.’s EPS estimate is $0.
          How many shares outstanding does Autonomix Medical, Inc. have?
          Autonomix Medical, Inc. has 1,152,149 shares outstanding.
            What happened to Autonomix Medical, Inc.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Autonomix Medical, Inc.?
            Currently, no hedge funds are holding shares in AMIX
            ---

            Autonomix Medical, Inc. Stock Smart Score

            Company Description

            Autonomix Medical, Inc.

            Autonomix, we¿re developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pancreatic cancer pain and pancreatitis pain.
            ---
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis